Relypsa sales and marketing update

Relypsa launched Veltassa patiromer in the U.S. to treat hyperkalemia. The wholesale acquisition cost (WAC) for the high-capacity oral potassium binder is $19.83 for a 25.2 g packet. The recommended ...